GARDASIL 9 is a vaccine that helps protect against disease caused by the following types of Human Papillomavirus (HPV): 6, 11, 16, 18, 31, 33, 45, 52 and 58. For more information, see Section 1.

The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is ...

Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong ...

Merck (MRK) anticipates full-year 2025 sales to be between $64.1B-$65.6B, including a negative impact of foreign exchange of approximately 2% ...

Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV ...

Kennedy Jr., President Trump’s nominee to run the Department of Health and Human Services, is giving away the fees that he could earn from litigation over Merck’s HPV vaccine Gardasil — to ...

"The approval of GARDASIL for use in males 9-26 years old in China is a significant step forward in advancing public health," said Joseph Romanelli, president, Human Health International ...

Mr. Kennedy told senators on Thursday that he had sent hundreds of cases to the firm for lawsuits against the drug maker Merck claiming injuries from the company’s Gardasil vaccine, which is ...

Public health researchers and doctors said there was no evidence that the vaccine, Gardasil, was linked to the health problems he cited, noting 160 favorable studies on safety. A federal court ...

During his time as a vaccine injury attorney, Kennedy launched complaints and lawsuits against Merck, the maker of Gardasil, which was first approved by the Food and Drug Administration in 2006.

The quadrivalent HPV vaccine (Saccharomyces cerevisiae) Gardasil is now approved for men aged 9 to 26 for the prevention of HPV16- and HPV18-associated anal cancer, genital warts (condyloma ...

In March 2024, the company announced its plans to commence two prospective clinical trials to evaluate the efficacy and safety of a single-dose regimen of its multivalent HPV vaccine, Gardasil 9.